Suchergebnisse - "Thuluvath, Paul J"

PubPharm (10)

1

Long-term follow-up of clinical trial patients treated for chronic HCV infection with daclatasvir-based regimens

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2018

von Reddy, K. | Pol, S. | Thuluvath, P. | +18

2

Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection

enthalten in: Annals of hepatology | 2016

von Rodriguez-Torres, M. | Lawitz, E. | Yangco, B. | +20

3

Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2016

von Everson, G. | Sims, K. | Thuluvath, P. | +17

CommentIn: Liver Int. 2016 Feb;36(2):181-4. - PMID 26781595

4

Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis

enthalten in: Gastroenterology | 2015

von Lawitz, E. | Makara, M. | Akarca, U. | +10

5

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection : a randomised study

enthalten in: Gut | 2015

von Hézode, C. | Hirschfield, G. | Ghesquiere, W. | +31

6

A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection

enthalten in: Journal of hepatology | 2015

von Hassanein, T. | Sims, K. | Bennett, M. | +16

CommentIn: J Hepatol. 2015 May;62(5):996-9. - PMID 25747660

7

All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection : ALLY-3 phase III study

enthalten in: Hepatology (Baltimore, Md.) | 2015

von Nelson, D. | Cooper, J. | Lalezari, J. | +23

CommentIn: Turk J Gastroenterol. 2016 Jan;27(1):89-90. - PMID 26728866

8

Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection

enthalten in: Gastroenterology | 2014

von Everson, G. | Sims, K. | Rodriguez-Torres, M. | +19

9

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

enthalten in: The New England journal of medicine | 2014

von Sulkowski, M. | Gardiner, D. | Rodriguez-Torres, M. | +22

ErratumIn: N Engl J Med. 2014 Apr 10;370(15):1469

10

Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection : a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial

enthalten in: The Lancet. Infectious diseases | 2012

von Pol, S. | Ghalib, R. | Rustgi, V. | +19

CommentIn: Lancet Infect Dis. 2012 Sep;12(9):648-9. - PMID 22714000

1
[1]